Phase 2 Study of Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorders
Phase of Trial: Phase II
Latest Information Update: 01 Nov 2017
At a glance
- Drugs Triheptanoin (Primary) ; Medium-chain triglyceride
- Indications Lipid metabolism disorders
- Focus Therapeutic Use
- 20 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 29 Sep 2014 Planned primary completion date changed from 1 Dec 2014 to 1 Mar 2015 as reported by ClinicalTrials.gov.
- 29 Sep 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.